Role of pneumococcal proteins in sensorineural hearing loss due to otitis media

Otology and Neurotology

Volumn 29, Issue 8, 2008, Pages 1056-1060

  Tsuprun, Vladimir ^a   Cureoglu, Sebahattin ^a   Schachern, Patricia A ^a   Ferrieri, Patricia ^b   Briles, David E ^a,c   Paparella, Michael M ^a   Juhn, Steven K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Alabama at Birmingham   (United States)

^c Paparella Ear Head and Neck Institute PA   (United States)

Author keywords

Inner ear; Mutant strains; Otitis media; Pneumococcal surface protein A; Pneumolysin; Sensorineural hearing loss; Streptococcus pneumoniae

Indexed keywords

BACTERIAL PROTEIN; HEAT SHOCK PROTEIN; PHAGE SHOCK PROTEIN, BACTERIA; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; PNEUMOCOCCAL SURFACE PROTEIN A; STREPTOLYSIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHINCHILLA; DISEASE MODEL; HEARING LOSS; MICROBIOLOGY; OTITIS MEDIA; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PERCEPTIVE THRESHOLD; PHYSIOLOGY; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; CHINCHILLA; DISEASE MODELS, ANIMAL; HEARING LOSS; HEARING LOSS, SENSORINEURAL; HEAT-SHOCK PROTEINS; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; SENSORY THRESHOLDS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 59849096658     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31818af3ad     Document Type: Article

References (32)

1. Margolis RH, Hunter LL, Saupe J.R., Giebink GS Effect of otitis media on extended high frequency hearing in children. Ann Otol Rhinol Laryngol 1993;102:1-5.
2. Margolis RH, Saly GL, Hunter L. High-frequency loss and wideband middle ear impedance in children with otitis media histories. Ear Hear 2000;21:206-11.
3. Hunter LL, Margolis RH, Rykken J.R., et al. High frequency hearing loss associated with otitis media. Ear Hear 1996;17:1-11.
4. Papp Z, Rezes S, Sziklai I. Sensorineural hearing loss in chronic otitis media. Otol Neurotol 2003;24:141-4.
5. Billings KR, Kenna MA Causes of pediatric sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 1999;125:517-21.
6. Paparella MM, Morizono T, Le C.T., et al. Sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol 1984;93:623-9.
7. Tarlow M. Otitis media: pathogenesis and medical sequelae. Ear Nose Throat J 1998;77:3-6.
8. Juhn SK, Jung TTK, Lin J, Rhee CK Effect of inflammatory mediators on middle ear pathology and inner ear function. Ann N Y Acad Sci 1997;830:130-42.
9. Morizono T, Giebink GS, Paparella M.M., Sikora MA, Shea D. Sen-sorineural hearing loss in experimental purulent otitis media due to Streptococcus pneumoniae. Arch Otolaryngol 1985;111:794-8.
10. Schachern PA, Paparella MM, Hyberston R, Sano S., Duvall AJ III. Bacterial tympanogenic labyrinthitis, meningitis and sensorineural damage. Arch Otolaryngol Head Neck Surg 1992;118:53-87.
11. Cook RD, Postma DS, Brinson G.M., Prazma J., Pillsbury HC Cyto-toxic changes in hair cells secondary to pneumococcal middle-ear infection. J Otolaryngol 1999;28:325-31.
12. Ichimiya I, Suzuki M, Hirano T., Mogi G. The influence of pneu-mococcal otitis media on the cochlear lateral wall. Hear Res 1999; 131:128-34.
13. Ghaheri BA, Kemton JB, Pillers D.A., Trune DR Cochlear cytokine gene expression in murine acute otitis media. Laryngoscope 2007; 117:22-9.
14. Cureoglu S, Schachern P, Paparella M.M., Lindgren BR Cochlear changes in chronic otitis media. Laryngoscope 2004;114:622-6.
15. Sato K, Quartey MK, Liebeler C.L., Le CT, Giebink GS Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model. Infect Immun 1996;64:1140-5.
16. Long JP, Tong HH, DeMaria TF Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model. Infect Immun 2004;72: 4309-13.
17. White P, Hermansson A, Svanborg D., Briles D, Prellner K. Effect of active immunization with a pneumococcal surface protein (PspA) and locally applied antibodies in experimental otitis media. ORL J Otolaryngol Relat Spec 1999;61:206-11.
18. Briles DE, Hollingshead SK, Nabors G.S., Paton JC, BrooksWalter A. The potential for using protein vaccines against otitis media caused by Streptococcus pneumoniae. Vaccine 2000;19: S87-95.
19. Marra A, Lawaon S, Asundi J.S., Brigham D., Hromockyj AE In vivo characterization of the psa genes from Streptococcus pneumo-niae in multiple models of infection. Microbiology 2002;148: 1483-91.
20. Rapola S, Jantti V, Haikala R., et al. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 2000;182:1146-52.
21. Simell B, Jaakkola T, Lahdenkari M., et al. Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media. Clin Vaccine Immunol 2006;13: 1177-9.
22. Schachern PA, Tsuprun V, Cureoglu S., et al. The round window membrane in otitis media. Effect of pneumococcal proteins. Oto-laryngol Head Neck Surg 2008;134:658-62.
23. Ren B, Szalai AJ, Hollingshead S.K., Briles DE Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 2004;72:114-22.
24. Shaper M, Hollingshead SK, Benjamin WH Jr, Briles DE PspA protects Streptococcus pneumoniae from killing by apolacto-ferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin. Infect Immun 2004;72:5031-40.
25. Comis SD, Osborne MP, Stephen J, et al. Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Otolaryngol 1993;113:152-9.
26. Berry AM, Ogunniyi AD, Miller D.C., Paton JC Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infect Immun 1999;67:981-5.
27. Skinner LJ, Beurg M, Mitchell T.J., Aran JM, Dulon D. Intraco-chlear perfusion of pneumolysin, a pneumococcal protein, rapidly abolishes auditory potentials in the guinea pig cochlea. Acta Oto-laryngol 2004;124:1000-7.
28. Franco-Vidal V., Beurg M, Darrrouzet V., Bebear JP, Skinner LJ, Dulon D. Zinc protection against pneumolysin toxicity on rat cochlear hair cells. Audiol Neurootol 2008;13:65-70.
29. Winter AJ, Comis SD, Osborne M.P., Stephen J., Tarlow MJ Oto-toxicity resulting from intracochlear perfusion of Streptococcus pneumoniae in the guinea pig is modified by cefotaxime or amox-ycillin pretreatment. J Infect 1998;36:73-7.
30. Sato K, Liebeler Carol L, Quartey MK, Le C.T., Giebink GS. Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect Immun 1999;67:1943-6.
31. Kubo T, Anniko M, Stenqvist M., Hsu W. Interleukin-2 affects cochlear function gradually but reversibly. ORL J Otorhinolaryngol Relat Spec 1998;60:272-7.
32. Iguchi H, Anniko M. Interleukin 8 can affect inner ear function. ORL J Otorhinolaryngol Relat Spec 1998;60:181-9. Disorders